van der Velden V H, Wierenga-Wolf A F, Adriaansen-Soeting P W, Overbeek S E, Möller G M, Hoogsteden H C, Versnel M A
Department of Immunology, Erasmus University and University Hospital Dijkzigt, Rotterdam, The Netherlands.
Clin Exp Allergy. 1998 Jan;28(1):110-20. doi: 10.1046/j.1365-2222.1998.00198.x.
Asthma is characterized by reversible airway obstruction, airway hyperresponsiveness, and chronic inflammation of the airways. Since peptides are able to produce many of the pathophysiological features which are characteristic of asthma, peptide-mediated inflammation is thought to play a role in this disease. The effects of peptides are modulated by peptidases, which are able to degrade peptides, mostly resulting in their inactivation.
In this study, we investigated the distribution of two peptidases, aminopeptidase N and dipeptidyl peptidase IV, in the human bronchus and determined whether their expression was altered in allergic asthmatics.
We first determined the distribution of aminopeptidase N and dipeptidyl peptidase IV in the human bronchus using immuno- and enzymehistochemistry and compared this with the distribution of neutral endopeptidase. Secondly, the expression of aminopeptidase N and dipeptidyl peptidase IV was determined in bronchial biopsies of healthy subjects (n = 8) and allergic asthmatics (n = 12).
Aminopeptidase N was localized in connective tissue, blood vessels, gland ducts, perichondrium, nerves and leucocytes (mainly mononuclear phagocytes, dendritic cells, and eosinophils). Dipeptidyl peptidase IV was localized in serosal glands, blood vessels, and T cells. Immunohistochemistry and enzymehistochemistry gave similar results. Comparison of the expression of aminopeptidase N and dipeptidyl peptidase IV in bronchial biopsies of healthy controls and atopic asthmatics revealed no significant differences in the lamina propria. In contrast, in the bronchial epithelium of atopic asthmatics an increased number of aminopeptidase N-positive cells could be found. Double-staining identified these cells as L25+ dendritic cells and eosinophils.
We conclude that expression of aminopeptidase N and dipeptidyl peptidase IV is restricted to specific sites within the human bronchus. Furthermore, in the bronchial epithelium of allergic asthmatics an increased number of aminopeptidase N-expressing dendritic cells and eosinophils can be found.
哮喘的特征为可逆性气道阻塞、气道高反应性和气道慢性炎症。由于肽能够产生许多哮喘特有的病理生理特征,因此肽介导的炎症被认为在该疾病中起作用。肽的作用受肽酶调节,肽酶能够降解肽,大多导致其失活。
在本研究中,我们调查了两种肽酶,氨肽酶N和二肽基肽酶IV,在人支气管中的分布,并确定它们在过敏性哮喘患者中的表达是否发生改变。
我们首先使用免疫组织化学和酶组织化学确定氨肽酶N和二肽基肽酶IV在人支气管中的分布,并将其与中性内肽酶的分布进行比较。其次,在健康受试者(n = 8)和过敏性哮喘患者(n = 12)的支气管活检组织中测定氨肽酶N和二肽基肽酶IV的表达。
氨肽酶N定位于结缔组织、血管、腺管、软骨膜、神经和白细胞(主要是单核吞噬细胞、树突状细胞和嗜酸性粒细胞)。二肽基肽酶IV定位于浆膜腺、血管和T细胞。免疫组织化学和酶组织化学结果相似。健康对照者和特应性哮喘患者支气管活检组织中氨肽酶N和二肽基肽酶IV表达的比较显示,固有层无显著差异。相反,在特应性哮喘患者的支气管上皮中,可发现氨肽酶N阳性细胞数量增加。双重染色确定这些细胞为L25 +树突状细胞和嗜酸性粒细胞。
我们得出结论,氨肽酶N和二肽基肽酶IV的表达局限于人支气管内的特定部位。此外,在过敏性哮喘患者的支气管上皮中,可发现表达氨肽酶N的树突状细胞和嗜酸性粒细胞数量增加。